5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Nov 20, 2024.
The trade is 12.4% of the 96,491 shares held after it.
No other insider sold within 30 days.
61 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO GOLDIN AVI sold about $175.3K of GNE on Nov 18, 2025, the largest insider sale at the company since 2023; 61 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 27, 2023.
1 other insider sold within 30 days.
61 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director COURTER JAMES A sold about $63.2K of GNE on Sep 12, 2024; 1 other insider sold within 30 days and 61 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Nov 29, 2023.
1 other insider sold within 30 days.
61 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO GOLDIN AVI sold about $6.9K of GNE on Sep 11, 2024; 1 other insider sold within 30 days and 61 funds added in the latest 13F quarter.
16 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
GNE planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
GNE mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
First Trust Dow Jones Select MicroCap Index Fund
$1.0M position · as of 2026-06-30
0.4%
Royce Quant Small-Cap Quality Value ETF
$68.3K position · as of 2026-06-30
0.2%
Victory Small Cap Stock Fund
$1.0M position · as of 2026-07-31
0.1%
Venerable US Small Cap Fund
$155.5K position · as of 2026-06-30
0.1%
NVIT Small Cap Value Fund
$192.3K position · as of 2026-06-30
0.1%
WisdomTree U.S. SmallCap Dividend Fund
$1.8M position · as of 2026-06-30
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Michael Stein
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.4M
$1.5M
$869.0K
+110%
+59%
2024
$3.5M
$1.5M
$1.4M
+133%
+37%
2023
$3.2M
$6.1M
$1.6M
+313%
+11%
2022
$2.4M
$2.0M
$1.2M
+49%
+19%
2021
$919.4K
$664.0K
$999.3K
-23%
+17%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 61 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$502.4M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GNE
FY Dec 2025
$502.0M
FY Dec 2024
$425.2M
FY Dec 2023
$428.7M
FY Dec 2022
n/a
FY Dec 2021
$363.7M
Jun 2026
$100.4M
Mar 2026
$142.3M
Dec 2025
$121.3M
Sep 2025
$138.3M
Jun 2025
$105.5M
Mar 2025
$136.8M
Dec 2024
$102.9M
Sep 2024
$111.9M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+7.7%
Jun 2026
+11.3%
Mar 2026
+2.0%
Dec 2025
+4.0%
Sep 2025
+4.9%
Jun 2025
+2.2%
Mar 2025
+7.6%
Dec 2024
-15.0%
Sep 2024
+9.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$12.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GNE
FY Dec 2025
$39.1M
FY Dec 2024
$64.0M
FY Dec 2023
$61.1M
FY Dec 2022
$79.7M
FY Dec 2021
$68.3M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
$13.6M
Dec 2024
$10.3M
Sep 2024
$21.9M
At each fiscal year end
Single quarter
Debt to equity
0.03x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity GNE
FY Dec 2025
0.03x
FY Dec 2024
0.04x
FY Dec 2023
0.02x
FY Dec 2022
0.02x
FY Dec 2021
0.04x
Jun 2026
0.03x
Mar 2026
0.03x
Dec 2025
0.03x
Sep 2025
0.04x
Jun 2025
0.05x
Mar 2025
0.05x
Dec 2024
0.04x
Sep 2024
0.02x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
2.91x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt GNE
FY Dec 2025
5.35x
FY Dec 2024
7.84x
FY Dec 2023
14.26x
FY Dec 2022
18.42x
FY Dec 2021
15.61x
Jun 2026
2.91x
Mar 2026
3.58x
Dec 2025
5.35x
Sep 2025
4.90x
Jun 2025
5.98x
Mar 2025
8.12x
Dec 2024
7.84x
Sep 2024
15.57x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+25.2%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+13.4%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.79x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GNE
FY Dec 2025
15.31x
FY Dec 2024
11.90x
FY Dec 2023
14.14x
FY Dec 2022
3.17x
FY Dec 2021
5.30x
Jun 2026
15.21x
Mar 2026
23.18x
Dec 2025
15.31x
Sep 2025
15.10x
Jun 2025
23.79x
Mar 2025
10.75x
Dec 2024
11.90x
Sep 2024
11.52x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -16%, PEG needs growth
PEG, trailing GNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.02x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GNE ranks highest on financial health (98th percentile) and growth (81st), and lowest on institutional and government (24th), among Utilities peers.
Financial health
98
Inputs
Debt to equity0.03x · 97 pct, sector of 113
Cash flow to debt2.91x · 98 pct, sector of 113
Growth
81
Inputs
Revenue growth, YoY+18.1% · 81 pct, sector of 119
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
24
Inputs
Funds adding, latest quarter61 · 24 pct, sector of 121
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
57
Inputs
Short interest, % of float+2.7% · 60 pct, sector of 162
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 106
New text in Risk Factors, latest 10-K+28.2% · 11 pct, sector of 111
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 0 present: the filed year and its quarters do not reconcile, so the trailing figure is withheld
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.